The aim of the present study was to emphasize the critical importance of the clinician's awareness of signet-ring cell carcinoma (SRCC) of the urinary bladder, a rare and aggressive disease entity.
A review of the current literature was conducted and a classic case of advanced SRCC of the urinary bladder is reported, clearly demonstrating the severity of this disease and the imperative need for standardized recommendations for the diagnostic work-up and management of urinary bladder SRCC.
The prognosis for patients with SRCC of the urinary bladder is poor, attributed to presentation at advanced stages following asymptomatic progression, inefficacy of multimodality therapy and possibly an aggressive underlying biological phenotype. Treatment options are limited and not well studied.
Given the rarity of SRCC, multi-institutional clinical trials and international cooperation are mandatory to improve survival for patients with primary SRCC of the bladder.
Scandinavian journal of urology. 2018 Jan 01 [Epub ahead of print]
Maria Elisabeth Lendorf, Line Hammer Dohn, Bara Á Dunga, Anand C Loya, Helle Pappot
a Department of Oncology , Rigshospitalet, University of Copenhagen , Copenhagen , Denmark., b Department of Pathology , Rigshospitalet, University of Copenhagen , Copenhagen , Denmark.